Sanofi Pasteur has blueprinted plans for a major new vaccine facility in Neuville-sur-Saône, Rhône, France, where the new vaccine against the dengue fever is already planned to be produced. This plant will become the group's third largest European center fully dedicated to vaccines by 2014. Report